From Pediatric Cancer Survivor to Collegiate Athlete Stevie Elams Journey Through Resilience and Advocacy
admin The trajectory of a collegiate athlete is typically defined by years of disciplined training, competitive...
Uncategorized
Neuroscience and Childhood Brain Cancer: Bridging The Gap
The national non-profit organization CureSearch for Children’s Cancer has officially announced Kathryn Taylor, PhD, as...
CureSearch National Board of Directors Appoints New Leadership to Accelerate Pediatric Cancer Research and Clinical Development
CureSearch for Children’s Cancer, a national nonprofit organization dedicated to ending childhood cancer by driving...
CureSearch for Childrens Cancer Unveils 2026 Community Impact Awards to Support Psychosocial Care and Holistic Healing for Pediatric Patients
CureSearch for Children’s Cancer, a leading national non-profit dedicated to ending childhood cancer, has officially...
Gold Ribbon Hero: Lauren Kate – ACCO
The medical community and the residents of East Tennessee are rallying behind Lauren Kate, a...
Brave Barbie doll provides a friend through treatment for kids with cancer
The landmark partnership between CureSearch for Children’s Cancer and global toy leader Mattel has reached...
Dr. Moghimi & team has tool to treat Acute Myeloid leukemia
Researchers at Children’s Hospital Los Angeles (CHLA), led by Dr. Babak Moghimi, have announced a...
Pioneering Cellular Immunotherapy for Pediatric Oncology Dr Hunter Jonus Advances Gamma Delta T Cell Research to Combat High Risk Neuroblastoma
In the evolving landscape of pediatric oncology, the quest for effective treatments for high-risk neuroblastoma...
Cedars-Sinai Researcher Dr. Joshua Breunig Named 2024 CureSearch Acceleration Initiative Awardee for Breakthrough Pediatric Brain Cancer Research
The landscape of pediatric oncology is witnessing a significant shift as innovative modeling techniques and...
FDA Grants Accelerated Approval to OJEMDA (tovorafenib) as First Targeted Therapy for Pediatric Low-Grade Glioma
The United States Food and Drug Administration (FDA) has granted accelerated approval to OJEMDA (tovorafenib),...
